New diabetes clinical trial: The Reducing Adverse Outcomes in Dialysis by Adjusting the pRescription for Dialysate Potassium Trial

Published on: July 03, 2025 at 11:00PM
Conditions: End Stage Kidney Disease
Interventions: Other: PKRxHD; Procedure: Dialysis
Sponsors: NYU Langone Health; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting
https://ift.tt/zK1y24N